Under item 3, we will consider whether to take in private item 4, which is consideration of the case for an inquiry into infection with hepatitis C following the evidence that we heard this afternoon. We will review that evidence and agree any follow-up action.
Even before we had taken today's evidence, I contacted the clerks and said that we needed to debate the issue. This is such an important issue that we need to discuss it in public. On a previous occasion, we discussed the hepatitis C issue in private session. That unfortunate set of circumstances resulted in various issues being debated when people did not know what the committee or individual members of the committee had said.
I do not have a fixed view on this matter; each case should be considered on its merits. There has been too much privacy surrounding this issue and that would be compounded if we discussed it in private. The item should be discussed in public.
I agree with what has been said.
I have no strong views and I do not get a strong feeling from the committee. Is anyone vociferously opposed to the issue being discussed in public?
No. I think that we all understand the reasons.
Are we therefore agreed that we will not take item 4 in private?
Members indicated agreement.
Previous
Subordinate LegislationNext
Hepatitis C